Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction.
about
Preventing the transmission of American trypanosomiasis and its spread into non-endemic countriesTolerance of benznidazole in treatment of Chagas' disease in adultsAccurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patientsFeasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans FrontièresMass spectrometry detection of G3m and IGHG3 alleles and follow-up of differential mother and neonate IgG3Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatmentsPCR-based screening and lineage identification of Trypanosoma cruzi directly from faecal samples of triatomine bugs from northwestern Argentina.Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina.Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina.Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus.Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia.International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.The investigation of congenital infection by Trypanosoma cruzi in an endemic area of Chile: three protocols explored in a pilot project.Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level.Mother-to-Child Transmission of Trypanosoma cruzi.Sensitive and specific detection of Trypanosoma cruzi DNA in clinical specimens using a multi-target real-time PCR approach.Cell death and serum markers of collagen metabolism during cardiac remodeling in Cavia porcellus experimentally infected with Trypanosoma cruziDetection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig modelControlling congenital and paediatric chagas disease through a community health approach with active surveillance and promotion of paediatric awarenessCavia porcellus as a model for experimental infection by Trypanosoma cruziPrevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis.Molecular epidemiology of domestic and sylvatic Trypanosoma cruzi infection in rural northwestern Argentina.Follow-up of an asymptomatic Chagas disease population of children after treatment with nifurtimox (Lampit) in a sylvatic endemic transmission area of Colombia.Negativation of Trypanosoma cruzi PCR within Six Months after Treatment of a Child with NifurtimoxLong-term reduction of Trypanosoma cruzi infection in sylvatic mammals following deforestation and sustained vector surveillance in northwestern Argentina.Therapy of chagas disease: implications for levels of prevention.Trypanosoma cruzi burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy.Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests.The sylvatic transmission cycle of Trypanosoma cruzi in a rural area in the humid Chaco of Argentina.Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participationCongenital transmission of Trypanosoma cruzi in non-endemic areas: evaluation of a screening program in a tertiary care hospital in Barcelona, SpainBenznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease.Detection of Trypanosoma cruzi infection in naturally infected dogs and cats using serological, parasitological and molecular methods.Detection and Quantification of Viable and Nonviable Trypanosoma cruzi Parasites by a Propidium Monoazide Real-Time Polymerase Chain Reaction Assay.Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern ArgentinaMolecular characterization of trypanosomatid infections in wild howler monkeys (Alouatta caraya) in northeastern Argentina.Chagas disease and breast-feedingFrequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysisUsefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations.Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina.
P2860
Q28077539-33274B54-67D8-4192-AB46-918673C52721Q28292605-D79F92FF-236E-404F-BC7B-8FDE9044925AQ28475320-1FD4F163-6493-4FAF-BDF1-B7D3A58A0E3CQ28475694-5D7C131B-C786-4A5E-856F-A1E01234909AQ28483991-2DDE51DB-C9B2-42F8-A7BB-44CD8F299D91Q28535357-2E127F7F-F6F5-4DAA-84EB-E89B4BC59B2DQ33230892-34EBBEC8-B212-42AC-98F5-0E7573E8F711Q33578835-7E19F739-5294-4A87-AEE1-709380E8DD91Q33738243-A354DE7E-0F91-4D1F-92E6-44E7DB6FD775Q33749707-7B93C1FC-6ABA-4951-A010-A1BC58DEF2E3Q33754264-77C348EE-2E7C-4EEC-BA2A-FD6AA1578E93Q33802931-14040F6F-52AF-4236-BF4B-D7BAC6703DC4Q33854932-B566BCB7-E81A-429D-B160-91EA7E0335A2Q34018004-1C514CC9-E1E4-4BEE-A29E-4D947786BCEDQ34181705-604685F1-1EFF-470A-8602-C2CA9F753E92Q34339762-59B8283E-3217-4A59-807C-AAFE6D20A3FFQ34587023-3646C054-556A-4384-8545-E44D76BE9056Q34631821-DE5D56F2-644D-46AB-B3E1-85FC033CAE06Q34896661-C6654223-EF07-459B-987D-45D03DFE2830Q35069952-C12FC3D9-7498-4665-8457-46B721ADE287Q35095569-F72FD492-A47A-460F-921B-49637619EF3AQ35126958-F00EE016-4AB9-4B92-8045-79F3C18C147AQ35130398-310792FE-6061-47FF-A84B-4D1739856E9FQ35581924-3D6C8857-BCE9-40D4-92AA-1AF7E671394EQ35754109-3222E27B-BA2C-4704-AC09-C3403482DF5AQ35864834-84327FDB-0EE2-442E-9B52-7EBD0AF8D6B9Q35884080-7D15665D-B75F-4E21-91EF-65D9D7D19494Q36154765-3384C7D7-D520-4CD0-9477-8D326373ABDEQ36241199-32E9D1A5-581F-4B15-B8D6-11A8152C2B99Q36278397-D445E7D1-813C-4EAE-AE8B-AD25E668EDDCQ36450619-D41396CB-6DC7-41A4-A10C-57C27AA0B5FCQ36505372-0213BE32-2700-436F-A231-881AB425E0AEQ36911045-8EDF7F94-5D28-46F8-8EAB-E07854DADF11Q36958490-5BCAD9A5-78E7-479A-A0D8-D257FBC27CDFQ37007518-29A1AB6F-8B48-4DE9-AFE7-5AA2A4CEE74BQ37218459-8B25B8C8-FF64-4CB6-A04C-BB130BF81B26Q37261944-F8405865-2123-47D9-B7BC-F148970EBF94Q37557805-207196C7-E804-44C7-A8D4-7FED3DC3D4E6Q37597052-A8C46D47-AE24-4005-82E8-6F9FE93CB9E7Q37597055-F4544372-04B8-44B7-87B2-924429F5018E
P2860
Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Aetiological treatment of cong ...... the polymerase chain reaction.
@en
Aetiological treatment of cong ...... the polymerase chain reaction.
@nl
type
label
Aetiological treatment of cong ...... the polymerase chain reaction.
@en
Aetiological treatment of cong ...... the polymerase chain reaction.
@nl
prefLabel
Aetiological treatment of cong ...... the polymerase chain reaction.
@en
Aetiological treatment of cong ...... the polymerase chain reaction.
@nl
P2093
P50
P356
P1476
Aetiological treatment of cong ...... the polymerase chain reaction.
@en
P2093
Héctor Freilij
Juan M Burgos
Mariano J Levin
Miguel Biancardi
P304
P356
10.1093/JAC/DKG338
P407
P577
2003-08-13T00:00:00Z